Moody's Investors Service assigned a "Baa1" rating to Akron, Ohio-based Summa Health's proposed $344 million of series 2016 bonds.
The rating assignment is based on a number of factors, including Summa's leading market position in its service area and strong unrestricted investments.
The outlook is stable, reflecting Moody's Investors Service's expectation that Summa's operating cash flow and liquidity will remain relatively stable.